Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Chemicals

Iofina appoints Chrystal Capital as it looks to drive shareholder value

The company will further explore business partnerships and combinations in the market and explore wider opportunities to drive shareholder value with the support of Chrystal Capital

Iofina PLC (AIM:IOF, OTC:IOFNF), the manufacturer of speciality chemical products and specialists in the exploration and production of iodine, has appointed Chrystal Capital as a financial advisory partner.

Chrystal Capital will be providing strategic advice on the company's approach to the equity markets and business growth, including helping to engage with new investment funds, single family offices and ultra high net worth individuals.

"Over the past few years, we have worked hard to position Iofina as one of the lowest cost iodine producers in the world in a market that continues to show solid growth. The appointment of Chrystal Capital Partners solidifies our intent to consider and evaluate opportunities to grow the business beyond our organic growth plans. We look forward to working closely with Chrystal Capital to assess how we can further unlock and drive shareholder value going forward,” said Tom Becker, the president and chief executive officer of Iofina.

Chrystal Capital Partners was initially involved with Iofina as a private company and was involved in bringing it to the London stock market in 2008.

“I'm personally delighted to be working with the Iofina management team again to assist in the next stage of growth to build value. The iodine and iodine derivatives market globally is in robust health and there are multiple opportunities for Iofina, with a strong market reputation and solid financial strength, to take advantage of to scale the existing business,” said Kingsley Wilson, a partner at Chrystal Capital.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK